Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?

Authors:

Abstract
Abstract: It has been hypothesized that a central event in the early pathogenesis of sporadic Alzheimer disease (SAD) is the dysfunction of the neuronal insulin receptor signal transduction. To prove this, this receptor was inhibited by a triplicate icv application of STZ. Insulin binding sites were upregulated as in SAD. With respect to glucose transport proteins, detailed investigations are necessary.

This publication has 8 references indexed in Scilit: